Related Experiment Video
Updated: Apr 18, 2026
06:27
Accelerated Type 1 Diabetes Induction in Mice by Adoptive Transfer of Diabetogenic CD4+ T Cells
Published on: May 6, 2013
17.5K
Interleukin-6: a possible inflammatory link between vitiligo and type 1 diabetes
J Farhan1, H A Al-Shobaili, U Zafar
1Department of Medical Biochemistry, Qassim University, Buraidah, KSA.
British Journal of Biomedical Science
|January 8, 2015
Summary
This study reveals higher inflammatory markers, particularly interleukin-6 (IL-6), in patients with both vitiligo and type 1 diabetes (T1D). These findings suggest IL-6 plays a key role in the pathogenesis of vitiligo-associated T1D.
Area of Science:
- Immunology
- Dermatology
- Endocrinology
Background:
- Vitiligo is an autoimmune pigmentation disorder.
- Vitiligo is often associated with other autoimmune conditions like type 1 diabetes mellitus (T1D).
- The inflammatory link between vitiligo and T1D requires further investigation.
Purpose of the Study:
- To investigate inflammatory markers tumor necrosis factor-alpha (TNFα), interleukin-6 (IL-6), and IL-1 in patients with vitiligo, T1D, and vitiligo-associated T1D (Vt-T1D).
- To explore the contribution of these inflammatory markers to the pathogenesis of these conditions.
Main Methods:
- Serum samples were collected from patients with Vt-T1D (n=21), vitiligo (n=39), T1D (n=37), and healthy controls (n=42).
- Levels of TNFα, IL-6, and IL-1β were measured in the serum samples.
Main Results:
- Vt-T1D patients exhibited significantly higher levels of TNFα, IL-6, and IL-1β compared to vitiligo, T1D patients, and controls.
- Serum IL-6 levels were notably higher in Vt-T1D patients than TNFα and IL-1β.
- IL-6 levels were elevated in vitiligo patients compared to TNFα and IL-1β, while T1D patients showed similar IL-6 and TNFα levels, both higher than IL-1β.
Conclusions:
- This study establishes an inflammatory link between vitiligo and T1D.
- Interleukin-6 (IL-6) appears to play a crucial role in the pathogenesis of vitiligo-associated T1D.
- IL-6 may represent a promising therapeutic target for patients with Vt-T1D.
Related Concept Videos
01:26Type I Diabetes II: Pathophysiology
1
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular...
1
01:12Type I Diabetes I: Introduction
1
Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1...
1
01:24Type II Diabetes II: Pathophysiology
2
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
2
01:19Psychoneuroimmunology: Diabetes and Cancer
655
Chronic stress has been linked to both the onset and progression of serious health conditions, including Type 2 diabetes and cancer. Type 2 diabetes, a widespread chronic illness, is closely associated with obesity and insulin resistance, both of which often worsen under stress. Studies indicate that men experiencing high levels of chronic stress face a 45% higher risk of developing diabetes compared to those with minimal stress. Stress triggers physiological responses that elevate blood...
655
01:24T Cell Types and Functions
3.5K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
3.5K
01:19Type I Diabetes III: Clinical Manifestations
9
Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the...
9